Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2300072493Phase 4Not yet recruiting
Phase 4, open-label trial of influenza vaccine in influenza (2 arms), sponsored by Sun Yat-sen University. Primary endpoint: Polymerase chain reaction-confirmed influenza infection. Planned start Sep 2023; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2300072493.